#hepatitis-b

#hepatitis-b

the research would have followed 14,000 infants in the West African nation of Guinea-Bissau. The problem? Only 7,000 of those newborns would have received an urgently needed hepatitis B vaccine, in order to compare the two groups. On top of the flagrant ethics violations, the total cost of the research would have exceeded the cost to pay for "over a decade's worth of Hepatitis B vaccine birth doses [for everyone] in Guinea-Bissau."